Detalhe da pesquisa
1.
Visualizing External Validity: Graphical Displays to Inform the Extension of Treatment Effects from Trials to Clinical Practice.
Epidemiology
; 35(2): 241-251, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290143
2.
Real-world comparative effectiveness of palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer.
Future Oncol
; 20(12): 761-780, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38231045
3.
Real-world relationship of early end points to survival end points in patients with resectable non-small-cell lung cancer.
Future Oncol
; 19(26): 1785-1800, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37665271
4.
Durvalumab real-world treatment patterns and outcomes in patients with stage III non-small-cell lung cancer treated in a US community setting.
Future Oncol
; 19(28): 1905-1916, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37497677
5.
The nuclear receptors SF1 and COUP-TFII cooperate on the Insl3 promoter in Leydig cells.
Reproduction
; 164(2): 31-40, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35666805
6.
Real-world outcomes of systemic therapy in locally advanced, recurrent or metastatic cutaneous squamous cell carcinoma.
Future Oncol
; 18(17): 2087-2099, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35240857
7.
A 35-bp Conserved Region Is Crucial for Insl3 Promoter Activity in Mouse MA-10 Leydig Cells.
Int J Mol Sci
; 23(23)2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36499388
8.
Recurrence rates in patients with HER2+ breast cancer who achieved a pathological complete response after neoadjuvant pertuzumab plus trastuzumab followed by adjuvant trastuzumab: a real-world evidence study.
Breast Cancer Res Treat
; 187(3): 903-913, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649981
9.
Treatment patterns and outcomes of patients with advanced malignant pleural mesothelioma in a community practice setting.
Future Oncol
; 17(19): 2439-2448, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33769073
10.
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.
Breast Cancer Res
; 21(1): 39, 2019 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867034
11.
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.
N Engl J Med
; 375(3): 209-19, 2016 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27264120
12.
Outcomes in patients with metastatic bladder cancer in the USA: a retrospective electronic medical record study.
Future Oncol
; 15(12): 1323-1334, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30942088
13.
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 17(3): 367-377, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26874901
14.
Adjuvant trastuzumab in HER2-positive breast cancer.
N Engl J Med
; 365(14): 1273-83, 2011 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21991949
15.
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer.
Breast Cancer Res Treat
; 147(3): 579-88, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25209003
16.
The nuclear receptor NR2F2 activates star expression and steroidogenesis in mouse MA-10 and MLTC-1 Leydig cells.
Biol Reprod
; 91(1): 26, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24899578
17.
Job attributes, job satisfaction and the return to health after breast cancer diagnosis and treatment.
Psychooncology
; 23(2): 158-64, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24000141
18.
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.
Lancet Oncol
; 14(11): 1121-1128, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24007746
19.
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).
J Clin Oncol
; 42(12): 1344-1349, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38335467
20.
Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, HER2-positive early breast cancer: results from the BCIRG 006 Study.
Oncologist
; 18(7): 812-8, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23814044